Journal Article Review Epublish 22 citations
PubMed: 35054174 DOI: 10.3390/diagnostics12010004
Lymphatic Endothelial Markers and Tumor Lymphangiogenesis Assessment in Human Breast Cancer.
Diagnostics (Basel) 12(1)
Authors: Jia-Mei Chen, Bo Luo, Ru Ma, Xi-Xi Luo, Yong-Shun Chen, Yan Li
Affiliations
- Center of Oncology, Renmin Hospital of Wuhan University, Wuhan 430060, China.
- Department of Pathology, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430014, China.
- Department of Peritoneal Cancer Surgery, Beijing Shijitan Hospital of Capital Medical University, Beijing 100038, China.
- Department of Peritoneal Cancer Surgery, Beijing Shijitan Hospital of Capital Medical University, Beijing 100038, China. Department of Pathology, Beijing Shijitan Hospital, Capital Medical University, Beijing 100038, China.
Abstract
Metastasis via lymphatic vessels or blood vessels is the leading cause of death for breast cancer, and lymphangiogenesis and angiogenesis are critical prerequisites for the tumor invasion-metastasis cascade. The research progress for tumor lymphangiogenesis has tended to lag behind that for angiogenesis due to the lack of specific markers. With the discovery of lymphatic endothelial cell (LEC) markers, growing evidence demonstrates that the LEC plays an active role in lymphatic formation and remodeling, tumor cell growth, invasion and intravasation, tumor-microenvironment remodeling, and antitumor immunity. However, some studies have drawn controversial conclusions due to the variation in the LEC markers and lymphangiogenesis assessments used. In this study, we review recent findings on tumor lymphangiogenesis, the most commonly used LEC markers, and parameters for lymphangiogenesis assessments, such as the lymphatic vessel density and lymphatic vessel invasion in human breast cancer. An in-depth understanding of tumor lymphangiogenesis and LEC markers can help to illustrate the mechanisms and distinct roles of lymphangiogenesis in breast cancer progression, which will help in exploring novel potential predictive biomarkers and therapeutic targets for breast cancer.
MeSH
Cells, Breast Neoplasms, Lymphatic Vessels, Lymphangiogenesis
Cited by
- The global landscape and research trend of lymphangiogenesis in breast cancer: a bibliometric analysis and visualization. Front Oncol, 2024
- Molecular and Cellular Machinery of Lymphatic Metastasis in Breast Cancer. Onco Targets Ther, 2025
- High microvessel and lymphatic vessel density predict poor prognosis in patients with esophageal squamous cell carcinoma. PeerJ, 2024
- Transcriptomic and Functional Evidence That miRNA193a-3p Inhibits Lymphatic Endothelial Cell (LEC) and LEC + MCF-7 Spheroid Growth Directly and by Altering MCF-7 Secretome. Cells, 2023
- Transcriptomic and Functional Evidence for Differential Effects of MCF-7 Breast Cancer Cell-Secretome on Vascular and Lymphatic Endothelial Cell Growth. Int J Mol Sci, 2022
- Effect of Narrative Nursing on Family Resilience and Psychosocial Adaptation of Middle-Aged Patients with Breast Cancer. Evid Based Complement Alternat Med, 2022
- Anticancer effects of purple carrot extract via induction of apoptotic genes on human breast cancer cells. Food Sci Biotechnol, 2025
- Endothelial cell alterations in capillaries of adipose tissue from patients affected by lipedema. Obesity (Silver Spring), 2025
- Lymphatic Endothelial-to-Myofibroblast Transition: A Potential New Mechanism Underlying Skin Fibrosis in Systemic Sclerosis. Cells, 2023